Global Transdermal Medical Patch Sales Market Report 2021

1 Transdermal Medical Patch Market Overview

• 1.1 Transdermal Medical Patch Product Scope
• 1.2 Transdermal Medical Patch Segment by Type
  • 1.2.1 Global Transdermal Medical Patch Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Methyl Salicylate-Based Patch
  • 1.2.3 Rivastigmine Patch
  • 1.2.4 Fentanyl Patch
  • 1.2.5 Lidocaine Patch
  • 1.2.6 Diclofenac Patch
  • 1.2.7 Nicotine Patch
  • 1.2.8 Others
• 1.3 Transdermal Medical Patch Segment by Application
  • 1.3.1 Global Transdermal Medical Patch Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Offline Channel
  • 1.3.3 Online Channel
• 1.4 Transdermal Medical Patch Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Transdermal Medical Patch Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Transdermal Medical Patch Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Transdermal Medical Patch Price Trends (2016-2027)

2 Transdermal Medical Patch Estimates and Forecasts by Region

• 2.1 Global Transdermal Medical Patch Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Transdermal Medical Patch Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Transdermal Medical Patch Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Transdermal Medical Patch Revenue Market Share by Region (2016-2021)
• 2.3 Global Transdermal Medical Patch Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Transdermal Medical Patch Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Transdermal Medical Patch Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Transdermal Medical Patch Estimates and Projections (2016-2027)
  • 2.4.2 Europe Transdermal Medical Patch Estimates and Projections (2016-2027)
  • 2.4.3 China Transdermal Medical Patch Estimates and Projections (2016-2027)
  • 2.4.4 Japan Transdermal Medical Patch Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Transdermal Medical Patch Estimates and Projections (2016-2027)
  • 2.4.6 India Transdermal Medical Patch Estimates and Projections (2016-2027)

3 Global Transdermal Medical Patch Competition Landscape by Players

• 3.1 Global Top Transdermal Medical Patch Players by Sales (2016-2021)
• 3.2 Global Top Transdermal Medical Patch Players by Revenue (2016-2021)
• 3.3 Global Transdermal Medical Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Medical Patch as of 2020)
• 3.4 Global Transdermal Medical Patch Average Price by Company (2016-2021)
• 3.5 Manufacturers Transdermal Medical Patch Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Transdermal Medical Patch Market Size by Type

• 4.1 Global Transdermal Medical Patch Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Transdermal Medical Patch Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Transdermal Medical Patch Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Transdermal Medical Patch Price by Type (2016-2021)
• 4.2 Global Transdermal Medical Patch Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Transdermal Medical Patch Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Transdermal Medical Patch Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Transdermal Medical Patch Price Forecast by Type (2022-2027)

5 Global Transdermal Medical Patch Market Size by Application

• 5.1 Global Transdermal Medical Patch Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Transdermal Medical Patch Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Transdermal Medical Patch Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Transdermal Medical Patch Price by Application (2016-2021)
• 5.2 Global Transdermal Medical Patch Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Transdermal Medical Patch Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Transdermal Medical Patch Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Transdermal Medical Patch Price Forecast by Application (2022-2027)

6 North America Transdermal Medical Patch Market Facts & Figures

• 6.1 North America Transdermal Medical Patch Sales by Company
  • 6.1.1 North America Transdermal Medical Patch Sales by Company (2016-2021)
  • 6.1.2 North America Transdermal Medical Patch Revenue by Company (2016-2021)
• 6.2 North America Transdermal Medical Patch Sales Breakdown by Type
  • 6.2.1 North America Transdermal Medical Patch Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Transdermal Medical Patch Sales Breakdown by Type (2022-2027)
• 6.3 North America Transdermal Medical Patch Sales Breakdown by Application
  • 6.3.1 North America Transdermal Medical Patch Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Transdermal Medical Patch Sales Breakdown by Application (2022-2027)

7 Europe Transdermal Medical Patch Market Facts & Figures

• 7.1 Europe Transdermal Medical Patch Sales by Company
  • 7.1.1 Europe Transdermal Medical Patch Sales by Company (2016-2021)
  • 7.1.2 Europe Transdermal Medical Patch Revenue by Company (2016-2021)
• 7.2 Europe Transdermal Medical Patch Sales Breakdown by Type
  • 7.2.1 Europe Transdermal Medical Patch Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Transdermal Medical Patch Sales Breakdown by Type (2022-2027)
• 7.3 Europe Transdermal Medical Patch Sales Breakdown by Application
  • 7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)

8 China Transdermal Medical Patch Market Facts & Figures

• 8.1 China Transdermal Medical Patch Sales by Company
  • 8.1.1 China Transdermal Medical Patch Sales by Company (2016-2021)
  • 8.1.2 China Transdermal Medical Patch Revenue by Company (2016-2021)
• 8.2 China Transdermal Medical Patch Sales Breakdown by Type
  • 8.2.1 China Transdermal Medical Patch Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Transdermal Medical Patch Sales Breakdown by Type (2022-2027)
• 8.3 China Transdermal Medical Patch Sales Breakdown by Application
  • 8.3.1 China 311 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 311 Sales Breakdown by Application (2022-2027)

9 Japan Transdermal Medical Patch Market Facts & Figures

• 9.1 Japan Transdermal Medical Patch Sales by Company
  • 9.1.1 Japan Transdermal Medical Patch Sales by Company (2016-2021)
  • 9.1.2 Japan Transdermal Medical Patch Revenue by Company (2016-2021)
• 9.2 Japan Transdermal Medical Patch Sales Breakdown by Type
  • 9.2.1 Japan Transdermal Medical Patch Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Transdermal Medical Patch Sales Breakdown by Type (2022-2027)
• 9.3 Japan Transdermal Medical Patch Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Transdermal Medical Patch Market Facts & Figures

• 10.1 Southeast Asia Transdermal Medical Patch Sales by Company
  • 10.1.1 Southeast Asia Transdermal Medical Patch Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Transdermal Medical Patch Revenue by Company (2016-2021)
• 10.2 Southeast Asia Transdermal Medical Patch Sales Breakdown by Type
  • 10.2.1 Southeast Asia Transdermal Medical Patch Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Transdermal Medical Patch Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Transdermal Medical Patch Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Transdermal Medical Patch Market Facts & Figures

• 11.1 India Transdermal Medical Patch Sales by Company
  • 11.1.1 India Transdermal Medical Patch Sales by Company (2016-2021)
  • 11.1.2 India Transdermal Medical Patch Revenue by Company (2016-2021)
• 11.2 India Transdermal Medical Patch Sales Breakdown by Type
  • 11.2.1 India Transdermal Medical Patch Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Transdermal Medical Patch Sales Breakdown by Type (2022-2027)
• 11.3 India Transdermal Medical Patch Sales Breakdown by Application
  • 11.3.1 India Transdermal Medical Patch Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Transdermal Medical Patch Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Transdermal Medical Patch Business

• 12.1 Hisamitsu Pharmaceutical
  • 12.1.1 Hisamitsu Pharmaceutical Corporation Information
  • 12.1.2 Hisamitsu Pharmaceutical Business Overview
  • 12.1.3 Hisamitsu Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Hisamitsu Pharmaceutical Transdermal Medical Patch Products Offered
  • 12.1.5 Hisamitsu Pharmaceutical Recent Development
• 12.2 Johnson & Johnson
  • 12.2.1 Johnson & Johnson Corporation Information
  • 12.2.2 Johnson & Johnson Business Overview
  • 12.2.3 Johnson & Johnson Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Johnson & Johnson Transdermal Medical Patch Products Offered
  • 12.2.5 Johnson & Johnson Recent Development
• 12.3 Novartis
  • 12.3.1 Novartis Corporation Information
  • 12.3.2 Novartis Business Overview
  • 12.3.3 Novartis Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Novartis Transdermal Medical Patch Products Offered
  • 12.3.5 Novartis Recent Development
• 12.4 UCB Pharma
  • 12.4.1 UCB Pharma Corporation Information
  • 12.4.2 UCB Pharma Business Overview
  • 12.4.3 UCB Pharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 UCB Pharma Transdermal Medical Patch Products Offered
  • 12.4.5 UCB Pharma Recent Development
• 12.5 Mylan
  • 12.5.1 Mylan Corporation Information
  • 12.5.2 Mylan Business Overview
  • 12.5.3 Mylan Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Mylan Transdermal Medical Patch Products Offered
  • 12.5.5 Mylan Recent Development
• 12.6 Teva Pharmaceutical
  • 12.6.1 Teva Pharmaceutical Corporation Information
  • 12.6.2 Teva Pharmaceutical Business Overview
  • 12.6.3 Teva Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Teva Pharmaceutical Transdermal Medical Patch Products Offered
  • 12.6.5 Teva Pharmaceutical Recent Development
• 12.7 Nitto Denko
  • 12.7.1 Nitto Denko Corporation Information
  • 12.7.2 Nitto Denko Business Overview
  • 12.7.3 Nitto Denko Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Nitto Denko Transdermal Medical Patch Products Offered
  • 12.7.5 Nitto Denko Recent Development
• 12.8 Grünenthal
  • 12.8.1 Grünenthal Corporation Information
  • 12.8.2 Grünenthal Business Overview
  • 12.8.3 Grünenthal Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Grünenthal Transdermal Medical Patch Products Offered
  • 12.8.5 Grünenthal Recent Development
• 12.9 IBSA Group
  • 12.9.1 IBSA Group Corporation Information
  • 12.9.2 IBSA Group Business Overview
  • 12.9.3 IBSA Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 IBSA Group Transdermal Medical Patch Products Offered
  • 12.9.5 IBSA Group Recent Development
• 12.10 GSK
  • 12.10.1 GSK Corporation Information
  • 12.10.2 GSK Business Overview
  • 12.10.3 GSK Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 GSK Transdermal Medical Patch Products Offered
  • 12.10.5 GSK Recent Development
• 12.11 Luye Pharma Group
  • 12.11.1 Luye Pharma Group Corporation Information
  • 12.11.2 Luye Pharma Group Business Overview
  • 12.11.3 Luye Pharma Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Luye Pharma Group Transdermal Medical Patch Products Offered
  • 12.11.5 Luye Pharma Group Recent Development
• 12.12 Pfizer
  • 12.12.1 Pfizer Corporation Information
  • 12.12.2 Pfizer Business Overview
  • 12.12.3 Pfizer Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Pfizer Transdermal Medical Patch Products Offered
  • 12.12.5 Pfizer Recent Development
• 12.13 Chattem
  • 12.13.1 Chattem Corporation Information
  • 12.13.2 Chattem Business Overview
  • 12.13.3 Chattem Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Chattem Transdermal Medical Patch Products Offered
  • 12.13.5 Chattem Recent Development
• 12.14 Dr Reddy’s Laboratories
  • 12.14.1 Dr Reddy’s Laboratories Corporation Information
  • 12.14.2 Dr Reddy’s Laboratories Business Overview
  • 12.14.3 Dr Reddy’s Laboratories Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Dr Reddy’s Laboratories Transdermal Medical Patch Products Offered
  • 12.14.5 Dr Reddy’s Laboratories Recent Development
• 12.15 Bayer
  • 12.15.1 Bayer Corporation Information
  • 12.15.2 Bayer Business Overview
  • 12.15.3 Bayer Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Bayer Transdermal Medical Patch Products Offered
  • 12.15.5 Bayer Recent Development
• 12.16 Mundipharma
  • 12.16.1 Mundipharma Corporation Information
  • 12.16.2 Mundipharma Business Overview
  • 12.16.3 Mundipharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Mundipharma Transdermal Medical Patch Products Offered
  • 12.16.5 Mundipharma Recent Development
• 12.17 Endo International
  • 12.17.1 Endo International Corporation Information
  • 12.17.2 Endo International Business Overview
  • 12.17.3 Endo International Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.17.4 Endo International Transdermal Medical Patch Products Offered
  • 12.17.5 Endo International Recent Development
• 12.18 Beijing Tide Pharmaceutical
  • 12.18.1 Beijing Tide Pharmaceutical Corporation Information
  • 12.18.2 Beijing Tide Pharmaceutical Business Overview
  • 12.18.3 Beijing Tide Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 12.18.4 Beijing Tide Pharmaceutical Transdermal Medical Patch Products Offered
  • 12.18.5 Beijing Tide Pharmaceutical Recent Development

13 Transdermal Medical Patch Manufacturing Cost Analysis

• 13.1 Transdermal Medical Patch Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Transdermal Medical Patch
• 13.4 Transdermal Medical Patch Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Transdermal Medical Patch Distributors List
• 14.3 Transdermal Medical Patch Customers

15 Market Dynamics

• 15.1 Transdermal Medical Patch Market Trends
• 15.2 Transdermal Medical Patch Drivers
• 15.3 Transdermal Medical Patch Market Challenges
• 15.4 Transdermal Medical Patch Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List